Geron reported $-0.02 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 -0.01 -0.03 Nov/04
FY2026Q2 Jun/2026 -0.02 -0.01 -0.02 Aug/05
FY2026Q1 Mar/2026 -0.01 -0.02 -0.03 May/06
FY2025Q4 Dec/2025 -0.05 -0.03 -0.04 Feb/25
FY2025Q3 Sep/2025 -0.03 -0.03 -0.04 Nov/05




Eps Change Date
Amgen USD 6.29 1.14 Jun/2026
Bio Techne USD 0.52 0.01 Jun/2026
Cassava Sciences USD -0.21 0.05 Mar/2026
Cytokinetics USD -1.5 0.17 Jun/2026
Exelixis USD 0.94 0.03 Sep/2026
Genmab DKK 5.43 4.6 Jun/2026
Geron USD -0.02 0.01 Jun/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
MacroGenics USD -0.58 0.36 Mar/2026
Novartis USD 2.46 0.05 Sep/2026
Novavax USD 0.13 0.59 Dec/2025